NLGN4X

NLGN4X is a postsynaptic cell-adhesion molecule that binds presynaptic neurexins to promote synapse formation and regulate the balance of excitatory and inhibitory circuit activity (PMID:12669065, PMID:24104404). Its surface expression and synaptogenic function depend on a single critical amino acid that distinguishes it from its Y-linked paralog NLGN4Y, and autism-associated mutations clustering near this residue phenocopy NLGN4Y's severe functional deficits (PMID:32243781). Phosphorylation of serine 712 by PKA and Cdk5 bidirectionally controls dendritic spine density and excitatory synaptic transmission, with the phosphorylated state reducing mushroom spines and the unphosphorylated state enhancing spine density and mEPSC frequency (PMID:40032531). Loss-of-function mutations in NLGN4X cause X-linked autism-spectrum disorder and intellectual disability, consistent with its requirement for neurite formation and expression of downstream postsynaptic scaffold genes including DLG4 (PMID:12669065, PMID:23710042).

1. 2003 High

   Identification of loss-of-function NLGN4X mutations in siblings with autism established this synaptic cell-adhesion molecule as a causative gene for neurodevelopmental disease, raising the question of how its molecular function at synapses relates to pathogenesis.

   Evidence Mutation screening in affected human siblings; protein localization at synapse

   PMID:12669065

   Open questions at the time

   • No functional characterization of how the identified mutations disrupt synaptogenesis
   • Expression pattern and synaptic subtype specificity of NLGN4X not defined
2. 2004 Medium

   A truncating frameshift in NLGN4X was predicted to ablate the transmembrane domain and sequences required for dimerization and neurexin binding, providing the first structural rationale for how NLGN4X mutations disrupt trans-synaptic adhesion.

   Evidence Sequencing of X-linked intellectual disability/autism pedigree; protein domain analysis of truncation

   PMID:14963808

   Open questions at the time

   • Functional effect of truncation not tested experimentally in cells or neurons
   • Whether partial protein products are expressed and exert dominant-negative effects was unknown
3. 2012 Medium

   Nlgn4 knockout mice recapitulated core autism-relevant behaviors—reduced social interaction, communication deficits, and stereotypies—in both sexes, confirming that NLGN4X loss of function is sufficient to produce behavioral phenotypes.

   Evidence Behavioral battery in Nlgn4-null mice including social interaction, ultrasonic vocalization, and repetitive behavior assays

   PMID:23183221

   Open questions at the time

   • Circuit-level and synaptic mechanisms underlying the behavioral deficits were not identified
   • Mouse Nlgn4 diverges from human NLGN4X, limiting direct translation
4. 2013 Medium

   Electrophysiological analysis of Nlgn4-knockout cortex revealed decreased network responses and a reduced excitation-inhibition ratio, establishing that NLGN4X regulates the E/I balance rather than solely excitatory or inhibitory synaptogenesis.

   Evidence Multi-electrode array and patch-clamp recordings in somatosensory cortical slices from Nlgn4-KO versus wild-type juvenile mice

   PMID:24104404

   Open questions at the time

   • Whether the E/I imbalance arises from selective loss of specific synapse types was not resolved
   • Developmental versus acute contributions of Nlgn4 loss were not distinguished
5. 2013 Medium

   NLGN4X knockdown in human neural stem cells impaired neurite formation and reduced expression of key postsynaptic scaffold genes (DLG4, NLGN1, NLGN3), placing NLGN4X upstream of broader synaptogenic transcriptional programs during neuronal differentiation.

   Evidence shRNA knockdown in differentiating human neural stem cells; morphological analysis and genome-wide expression profiling

   PMID:23710042

   Open questions at the time

   • Whether the transcriptional changes are direct or secondary to failed neurite outgrowth is unknown
   • Rescue experiments with wild-type NLGN4X were not reported
6. 2020 High

   A single critical amino acid distinguishing NLGN4X from NLGN4Y was shown to control protein maturation, surface trafficking, and synaptogenic activity, and ASD-associated mutations near this residue phenocopied NLGN4Y's severe deficits, explaining why the Y paralog cannot compensate for NLGN4X loss.

   Evidence Protein maturation/surface expression assays, electrophysiology, and imaging in heterologous cells and neurons with site-directed mutagenesis

   PMID:32243781

   Open questions at the time

   • Structural basis for how this residue controls folding and ER exit is not resolved
   • In vivo confirmation of NLGN4Y non-compensation in a mammalian model is lacking
7. 2024 Medium

   In melanoma, NLGN4X suppression was found to downregulate VBP1, causing HIF1A accumulation and HIF1A-dependent migration, revealing an unexpected non-neuronal role for NLGN4X in tumor biology.

   Evidence Loss- and gain-of-function in melanoma cells; transcriptomics; tumorsphere grafting to human skin organoids

   PMID:38902533

   Open questions at the time

   • Mechanism linking NLGN4X to VBP1 regulation is undefined
   • Relevance to in vivo melanoma progression not established beyond organoid model
   • Whether this pathway operates in other cancer types is unknown
8. 2025 High

   Phosphorylation of NLGN4X at S712 by PKA (X-specific) and Cdk5 was shown to bidirectionally regulate spine morphogenesis and excitatory synaptic transmission, providing the first post-translational mechanism for dynamic modulation of NLGN4X synaptogenic function.

   Evidence In vitro kinase assays with mutagenesis; spine density imaging and mEPSC recordings in neurons expressing phospho-mimetic and phospho-null S712 mutants

   PMID:40032531

   Open questions at the time

   • In vivo relevance of S712 phosphorylation to behavior or circuit function not tested
   • Whether S712 phosphorylation affects neurexin binding affinity is unknown
   • Upstream signals triggering PKA- versus Cdk5-mediated phosphorylation at this site are not defined

• Key unresolved questions include the structural basis for the NLGN4X/NLGN4Y functional divergence, the identity of signals that dynamically regulate S712 phosphorylation in vivo, and whether the non-neuronal VBP1-HIF1A pathway represents a physiologically relevant NLGN4X function outside the nervous system.
• No high-resolution structure of NLGN4X in complex with neurexin
• In vivo phospho-S712 dynamics have not been measured
• Non-neuronal functions lack independent replication